Summary Kadimastem Ltd (Kadimastem) is a regenerative medicine company that develops stem cell-based therapeutics for diabetes and neurodegenerative disorders. The company offers human pluripotent stem cell technology, based on differentiation of human embryonic stem cells towards insulin producing beta cells, and glucagon producing alpha cells arranged in islet-like clusters. Its technology is a combination of purification capabilities with a specific differentiation process of the islet-like ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.